Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:37 pm Purchase |
2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
RA Capital Management, L.P. | 3,181,818 4.700% |
86,682 (+2.80%) |
Filing History |
| 2025-02-12 09:33 am Purchase |
2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 5,750,000 8.420% |
1,958,580 (+51.66%) |
Filing History |
| 2025-01-27 12:58 pm Purchase |
2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,137,567 6.100% |
125,519 (+3.13%) |
Filing History |
| 2024-11-14 3:10 pm Purchase |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Cormorant Asset Management LP | 8,325,000 12.200% |
2,286,765 (+37.87%) |
Filing History |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
PRICE T ROWE ASSOCIATES INC | 2,492,213 4.700% |
-30,491 (-1.21%) |
Filing History |
| 2024-11-12 2:31 pm Unchanged |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
The Vanguard Group | 3,048,182 5.690% |
0 (Unchanged) |
Filing History |
| 2024-11-12 09:33 am Sale |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 3,791,420 7.080% |
-1,364,879 (-26.47%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
BLACKROCK INC BLK |
4,155,158 7.800% |
0 (Unchanged) |
Filing History |
| 2024-11-07 4:27 pm Purchase |
2024-10-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
TCG Crossover GP II, LLC | 3,572,335 5.200% |
3,572,335 (New Position) |
Filing History |
| 2024-11-06 08:54 am Purchase |
2024-10-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FEDERATED HERMES INC. FHI |
3,707,364 5.440% |
3,707,364 (New Position) |
Filing History |
| 2024-11-04 11:57 am Purchase |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
The Vanguard Group | 3,048,182 5.690% |
3,048,182 (New Position) |
Filing History |
| 2024-10-31 12:51 pm Sale |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,012,048 7.500% |
-628,603 (-13.55%) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
BLACKROCK INC BLK |
4,155,158 7.800% |
4,155,158 (New Position) |
Filing History |
| 2024-05-01 5:08 pm Unchanged |
2024-04-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 5,156,299 9.900% |
0 (Unchanged) |
Filing History |
| 2024-04-30 8:53 pm Purchase |
2024-04-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 5,156,299 10.350% |
5,156,299 (New Position) |
Filing History |
| 2024-02-14 9:08 pm Sale |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
RA Capital Management, L.P. | 3,095,136 6.100% |
-313,570 (-9.20%) |
Filing History |
| 2024-02-14 10:02 am Purchase |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
PRICE T ROWE ASSOCIATES INC | 2,522,704 5.600% |
2,522,704 (New Position) |
Filing History |
| 2024-02-13 12:00 pm Purchase |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,774,389 9.990% |
1,363,179 (+39.96%) |
Filing History |
| 2024-02-07 07:54 am Purchase |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
ADAGE CAPITAL PARTNERS GP LLC | 4,466,420 9.150% |
2,516,420 (+129.05%) |
Filing History |
| 2024-02-06 10:55 am Purchase |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,640,651 9.500% |
510,514 (+12.36%) |
Filing History |